The Department of Health and Human Services (HHS) has been making progress on COVID-19 treatment, testing, and vaccine development.

HHS has developed partnership and collaboration opportunities with both federal and non-federal entities to provide treatment and other resources on COVID-19.

Operation Warp Speed is an unprecedented partnership between HHS and the Department of Defense, which will give us the capability to break records in delivering a safe and effective vaccine by simultaneously working on development, manufacturing, and distribution.

On June 29 HHS announced an agreement to secure large supplies of the drug remdesivir, from Gilead Sciences, as a treatment for COVID-19. The agreement allows American hospitals to purchase the drug in amounts allocated by HHS and state health departments.

Convalescent plasma (blood donated by recovered COVID-19 patients that contains antibodies for the virus) is being investigated for the treatment of COVID-19. HHS is working with the Mayo Clinic to provide nationwide access to this potential treatment and examine the results. If you or someone you know has recovered from COVID-19, learn more about plasma donation here.

HHS is extending its partnership with national pharmacy and grocery retail chains CVS, Rite-Aid, Walgreens, Quest (through services at Walmart), and eTrueNorth (through services at Kroger, Health Mart, and Walmart) to provide Americans convenient access to COVID-19 testing. Find a testing location near you!